The 130 potential targets of TJZYF's antiendometrial receptivity reduction effect are mainly related to 189 signaling pathways, including ovarian steroidogenesis, GnRH signaling pathway, relaxin signaling pathway, and transcriptional misregulation in cancer. This evidence concerns the gene GNRH1 and cancer.